Antunes-Ferreira, Mafalda
D’Ambrosi, Silvia
Arkani, Mohammad
Post, Edward
In ‘t Veld, Sjors G. J. G.
Ramaker, Jip
Zwaan, Kenn
Kucukguzel, Ece Demirel
Wedekind, Laurine E.
Griffioen, Arjan W.
Oude Egbrink, Mirjam
Kuijpers, Marijke J. E.
van den Broek, Daan
Noske, David P.
Hartemink, Koen J.
Sabrkhany, Siamack
Bahce, Idris
Sol, Nik
Bogaard, Harm-Jan
Koppers-Lalic, Danijela
Best, Myron G.
Wurdinger, Thomas
Funding for this research was provided by:
Horizon 2020 (Marie Skłodowska-Curie grant agreement No. 765492, Marie Skłodowska-Curie grant agreement No. 765492, Marie Skłodowska-Curie grant agreement No. 765492, Marie Skłodowska-Curie grant agreement No. 765492)
Stichting STOPhersentumoren.nl
Article History
Received: 11 January 2023
Accepted: 24 May 2023
First Online: 8 June 2023
Competing interests
: MGB and TW are inventors on relevant patent applications. TW received financial compensation from Illumina, Inc and is shareholder of GRAIL, Inc. All other authors included in this study do not declare any competing interests.